Overview
Mentions in press and media 20
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 1, 2024 | Kedrion Selected by Biotest to Distribute its Immunoglobulin Yimmugo® in the U.S. Following Recent FDA Approval | CASTELVECCHIO PASCOLI, Italy, July 1, 2024 /PRNewswire/ -- Kedrion Biopharma Inc. announced today that it has established the framework for a long-term agreement with Biotest AG for the full commercialization and distribution of the immunog... |
| Apr 17, 2024 | World Hemophilia Day 2024"Equitable access for all: recognizing all bleeding disorders" | MONTREAL, April 17, 2024 /PRNewswire/ -- On April 17, 2024, the global bleeding disorders community will come together to celebrate World Hemophilia Day. The theme of the event this year is "Equitable access for all: recognizing all bl... |
| Nov 11, 2021 | November 11, 2021Grifols advances on the execution of its strategic plan | Business update · Third Quarter 2021 November 11, 2021 Grifols advances on the execution of its strategic plan through its investment in Biotest and agreement with GIC amid favorable U.S. market conditions Biotest AG's Management Board and ... |
| Nov 11, 2021 | Grifols advances on the execution of its strategic plan | November 11, 2021 Grifols advances on the execution of its strategic plan Print this news Download the press release Biotest AG's Management Board and Supervisory Board endorse Grifols' investment and recommend minority shareholders to acce... |
| Nov 11, 2021 | PRESS RELEASE : Biotest AG: Biotest increases sales by 9% in the first nine months 2021 | DGAP-News: Biotest AG / Key word(s): Quarter Results Biotest AG: Biotest increases sales by 9% in the first nine months 2021 2021-11-11 / 09:00 The issuer is solely responsible for the content of this announcement. -------------------------... |
| Nov 5, 2021 | PRESS RELEASE : Biotest AG: Joint reasoned statement of Biotest AG - Management Board and Supervisory Board recommend to accept takeover offer of GRIFOLS, S.A. | DGAP-News: Biotest AG / Key word(s): Statement Biotest AG: Joint reasoned statement of Biotest AG - Management Board and Supervisory Board recommend to accept takeover offer of GRIFOLS, S.A. 2021-11-05 / 09:46 The issuer is solely responsib... |
| Oct 13, 2021 | Grifols S A : October 13, 2021Grifols increases access to plasma-derived therapies as part of its commitment to donors and patients | Grifols increases access to plasma-derived therapies as part of its commitment to donors and patients For the month of October, Grifols supports International Plasma Awareness Week (IPAW), an initiative organized by the Plasma Protein Thera... |
| Oct 13, 2021 | Grifols S A : increases access to plasma-derived therapies as part of its commitment to donors and patients | October 13, 2021 Grifols increases access to plasma-derived therapies as part of its commitment to donors and patients Print this news Download the press release For the month of October, Grifols supports International Plasma Awareness Week... |
| Sep 20, 2021 | Evergrande is in trouble. But it probably won’t be a Lehman moment | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. It’s certainly eye-catching, but concerns that the collapse of Chinese property giant Evergrande ... |
Reviews 0
FAQ about Biotest AG
When was Biotest AG founded?
Biotest AG was founded in 1946.
What has the press written about Biotest AG?
Parsers VC has collected 20 articles mentioning Biotest AG, among them “Kedrion Selected by Biotest to Distribute its Immunoglobulin Yimmugo® in the U.S. Following Recent FDA Approval” (Jul 1, 2024) and “World Hemophilia Day 2024"Equitable access for all: recognizing all bleeding disorders"” (Apr 17, 2024).
Is Biotest AG still active?
Yes, Biotest AG is active; its latest activity on Parsers VC dates from Apr 17, 2025.